Patent classifications
C09B29/12
Composition for forming dye type polarizer and dye type polarizer
The present invention relates to a composition for forming a dye-type polarizer, which can be used to provide a dye-type polarizer showing excellent degree of polarization, heat resistance and dichroic ratio, and to a dye-type polarizer. The composition for forming a dye-type polarizer includes a curable anisotropic dye having a particular chemical structure; and an orientation auxiliary agent having a predetermined chemical structure.
Composition for forming dye type polarizer and dye type polarizer
The present invention relates to a composition for forming a dye-type polarizer, which can be used to provide a dye-type polarizer showing excellent degree of polarization, heat resistance and dichroic ratio, and to a dye-type polarizer. The composition for forming a dye-type polarizer includes a curable anisotropic dye having a particular chemical structure; and an orientation auxiliary agent having a predetermined chemical structure.
COLORING COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, LAMINATE, AND IMAGE DISPLAY DEVICE
An object of the invention is to provide a coloring composition with which a light absorption anisotropic film maintaining an excellent dichroic ratio and having good pressing resistance can be formed, and a light absorption anisotropic film, a laminate, and an image display device using the coloring composition. A coloring composition according to the invention contains: a polymer compound having a repeating unit including a crosslinkable group and a mesogenic group in the same side chain, or a polymer compound separately having a repeating unit including a crosslinkable group in a side chain and a repeating unit including a mesogenic group in a side chain; and a dichroic dye compound.
COLORING COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, LAMINATE, AND IMAGE DISPLAY DEVICE
An object of the invention is to provide a coloring composition with which a light absorption anisotropic film maintaining an excellent dichroic ratio and having good pressing resistance can be formed, and a light absorption anisotropic film, a laminate, and an image display device using the coloring composition. A coloring composition according to the invention contains: a polymer compound having a repeating unit including a crosslinkable group and a mesogenic group in the same side chain, or a polymer compound separately having a repeating unit including a crosslinkable group in a side chain and a repeating unit including a mesogenic group in a side chain; and a dichroic dye compound.
Azo dye composition and method for producing same
Provided are an azo dye composition including an azo dye compound represented by Formula (I) and a urea compound represented by Formula (II), and a method for producing an azo dye composition. R.sup.11, R.sup.12, R.sup.13 and R.sup.14 each independently represent a hydrogen atom, a halogen atom, or an aliphatic group; R.sup.15 represents an aliphatic group; R.sup.21 and R.sup.22 each independently represent a hydrogen atom, an aliphatic group, or an aromatic group; and n represents an integer from 0 to 2. ##STR00001##
Azo dye composition and method for producing same
Provided are an azo dye composition including an azo dye compound represented by Formula (I) and a urea compound represented by Formula (II), and a method for producing an azo dye composition. R.sup.11, R.sup.12, R.sup.13 and R.sup.14 each independently represent a hydrogen atom, a halogen atom, or an aliphatic group; R.sup.15 represents an aliphatic group; R.sup.21 and R.sup.22 each independently represent a hydrogen atom, an aliphatic group, or an aromatic group; and n represents an integer from 0 to 2. ##STR00001##
Small molecules that covalently modify transthyretin
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and ##STR00001##
reacts chemoselectively with one or two of four Lys-15 -amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.
Small molecules that covalently modify transthyretin
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and ##STR00001##
reacts chemoselectively with one or two of four Lys-15 -amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.
Small Molecules That Covalently Modify Transthyretin
A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and
##STR00001##
reacts chemoselectively with one or two of four Lys-15 -amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.
AZO DYE COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are an azo dye composition including an azo dye compound represented by Formula (I) and a urea compound represented by Formula (II), and a method for producing an azo dye composition. R.sup.11, R.sup.12, R.sup.13 and R.sup.14 each independently represent a hydrogen atom, a halogen atom, or an aliphatic group; R.sup.15 represents an aliphatic group; R.sup.21 and R.sup.22 each independently represent a hydrogen atom, an aliphatic group, or an aromatic group; and n represents an integer from 0 to 2.
##STR00001##